Iteos Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Iteos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iteos Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iteos Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $139k | 13k | 10.95 |
| 2023-09-30 | $139k | 13k | 10.95 |
| 2023-06-30 | $168k | 13k | 13.24 |
| 2023-03-31 | $173k | 13k | 13.61 |
| 2022-12-31 | $248k | 13k | 19.53 |
| 2022-09-30 | $242k | 13k | 19.05 |
| 2022-06-30 | $261k | 13k | 20.60 |
| 2022-03-31 | $408k | 13k | 32.18 |
| 2021-12-31 | $372k | 8.0k | 46.51 |
| 2021-09-30 | $216k | 8.0k | 27.00 |
| 2021-06-30 | $205k | 8.0k | 25.65 |
| 2021-03-31 | $273k | 8.0k | 34.18 |
| 2020-12-31 | $168k | 5.0k | 33.82 |
| 2020-09-30 | $122k | 5.0k | 24.58 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors